Logo image of MASS

908 DEVICES INC (MASS) Stock Fundamental Analysis

NASDAQ:MASS - Nasdaq - US65443P1021 - Common Stock - Currency: USD

7.33  +0.27 (+3.82%)

After market: 7.33 0 (0%)

Fundamental Rating

4

Overall MASS gets a fundamental rating of 4 out of 10. We evaluated MASS against 125 industry peers in the Electronic Equipment, Instruments & Components industry. MASS has a great financial health rating, but its profitability evaluates not so good. MASS is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year MASS has reported negative net income.
MASS had a negative operating cash flow in the past year.
MASS had negative earnings in each of the past 5 years.
In the past 5 years MASS reported 4 times negative operating cash flow.
MASS Yearly Net Income VS EBIT VS OCF VS FCFMASS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 -20M -40M -60M

1.2 Ratios

MASS has a worse Return On Assets (-9.02%) than 63.20% of its industry peers.
With a Return On Equity value of -11.09%, MASS perfoms like the industry average, outperforming 41.60% of the companies in the same industry.
Industry RankSector Rank
ROA -9.02%
ROE -11.09%
ROIC N/A
ROA(3y)-25.68%
ROA(5y)-18.55%
ROE(3y)-34.2%
ROE(5y)-24.45%
ROIC(3y)N/A
ROIC(5y)N/A
MASS Yearly ROA, ROE, ROICMASS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 -50 -100 -150 -200 -250

1.3 Margins

MASS's Gross Margin of 49.60% is amongst the best of the industry. MASS outperforms 86.40% of its industry peers.
MASS's Gross Margin has improved in the last couple of years.
MASS does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 49.6%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.03%
GM growth 5Y2.07%
MASS Yearly Profit, Operating, Gross MarginsMASS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100

8

2. Health

2.1 Basic Checks

MASS does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for MASS has been increased compared to 1 year ago.
Compared to 5 years ago, MASS has more shares outstanding
MASS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
MASS Yearly Shares OutstandingMASS Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
MASS Yearly Total Debt VS Total AssetsMASS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

An Altman-Z score of 3.27 indicates that MASS is not in any danger for bankruptcy at the moment.
MASS has a Altman-Z score of 3.27. This is comparable to the rest of the industry: MASS outperforms 52.80% of its industry peers.
There is no outstanding debt for MASS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 3.27
ROIC/WACCN/A
WACC9.54%
MASS Yearly LT Debt VS Equity VS FCFMASS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M

2.3 Liquidity

MASS has a Current Ratio of 7.62. This indicates that MASS is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of MASS (7.62) is better than 88.00% of its industry peers.
A Quick Ratio of 6.97 indicates that MASS has no problem at all paying its short term obligations.
MASS has a better Quick ratio (6.97) than 88.80% of its industry peers.
Industry RankSector Rank
Current Ratio 7.62
Quick Ratio 6.97
MASS Yearly Current Assets VS Current LiabilitesMASS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

5

3. Growth

3.1 Past

MASS shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -3.74%.
MASS shows a strong growth in Revenue. In the last year, the Revenue has grown by 21.06%.
Measured over the past years, MASS shows a very strong growth in Revenue. The Revenue has been growing by 27.11% on average per year.
EPS 1Y (TTM)-3.74%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%15.15%
Revenue 1Y (TTM)21.06%
Revenue growth 3Y12.21%
Revenue growth 5Y27.11%
Sales Q2Q%17.88%

3.2 Future

Based on estimates for the next years, MASS will show a very strong growth in Earnings Per Share. The EPS will grow by 22.96% on average per year.
MASS is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.69% yearly.
EPS Next Y34.05%
EPS Next 2Y22.96%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-4.98%
Revenue Next 2Y7.69%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
MASS Yearly Revenue VS EstimatesMASS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M
MASS Yearly EPS VS EstimatesMASS Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 -0.5 -1 -1.5

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for MASS. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for MASS. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MASS Price Earnings VS Forward Price EarningsMASS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MASS Per share dataMASS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2 3 4

4.3 Compensation for Growth

A more expensive valuation may be justified as MASS's earnings are expected to grow with 22.96% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y22.96%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for MASS!.
Industry RankSector Rank
Dividend Yield N/A

908 DEVICES INC

NASDAQ:MASS (7/23/2025, 4:30:01 PM)

After market: 7.33 0 (0%)

7.33

+0.27 (+3.82%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)05-13 2025-05-13/bmo
Earnings (Next)08-12 2025-08-12/bmo
Inst Owners72.92%
Inst Owner Change0%
Ins Owners5.58%
Ins Owner Change0.94%
Market Cap262.85M
Analysts84
Price Target5.61 (-23.47%)
Short Float %7.6%
Short Ratio4.08
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-21.57%
Min EPS beat(2)-58.68%
Max EPS beat(2)15.54%
EPS beat(4)3
Avg EPS beat(4)19.94%
Min EPS beat(4)-58.68%
Max EPS beat(4)113.88%
EPS beat(8)7
Avg EPS beat(8)18.98%
EPS beat(12)9
Avg EPS beat(12)11.59%
EPS beat(16)11
Avg EPS beat(16)8.01%
Revenue beat(2)1
Avg Revenue beat(2)4.81%
Min Revenue beat(2)-2.97%
Max Revenue beat(2)12.6%
Revenue beat(4)2
Avg Revenue beat(4)0.28%
Min Revenue beat(4)-10.3%
Max Revenue beat(4)12.6%
Revenue beat(8)5
Avg Revenue beat(8)3.04%
Revenue beat(12)7
Avg Revenue beat(12)2.61%
Revenue beat(16)11
Avg Revenue beat(16)3.53%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)-7.84%
EPS NQ rev (3m)20.29%
EPS NY rev (1m)7.41%
EPS NY rev (3m)20.21%
Revenue NQ rev (1m)-1.34%
Revenue NQ rev (3m)-1.28%
Revenue NY rev (1m)-0.06%
Revenue NY rev (3m)-1.52%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 4.28
P/FCF N/A
P/OCF N/A
P/B 1.65
P/tB 2.16
EV/EBITDA N/A
EPS(TTM)-1.11
EYN/A
EPS(NY)-0.57
Fwd EYN/A
FCF(TTM)-1
FCFYN/A
OCF(TTM)-1
OCFYN/A
SpS1.71
BVpS4.45
TBVpS3.39
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -9.02%
ROE -11.09%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 49.6%
FCFM N/A
ROA(3y)-25.68%
ROA(5y)-18.55%
ROE(3y)-34.2%
ROE(5y)-24.45%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.03%
GM growth 5Y2.07%
F-Score3
Asset Turnover0.31
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 3.06%
Cap/Sales 0.23%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 7.62
Quick Ratio 6.97
Altman-Z 3.27
F-Score3
WACC9.54%
ROIC/WACCN/A
Cap/Depr(3y)75.32%
Cap/Depr(5y)61.35%
Cap/Sales(3y)3.15%
Cap/Sales(5y)2.25%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-3.74%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%15.15%
EPS Next Y34.05%
EPS Next 2Y22.96%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)21.06%
Revenue growth 3Y12.21%
Revenue growth 5Y27.11%
Sales Q2Q%17.88%
Revenue Next Year-4.98%
Revenue Next 2Y7.69%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y20.61%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year62.96%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-6.04%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-15.43%
OCF growth 3YN/A
OCF growth 5YN/A